Combination therapeutics in complex diseases - Wikidata - wikimedia - TriplyDB

Combination therapeutics in complex diseases

Combination therapeutics in complex diseases

http://www.wikidata.org/entity/Q28076891

about

Therapeutic monoclonal antibodies and clinical laboratory tests: When, why, and what is expected?Precision medicine for hepatocellular carcinoma: driver mutations and targeted therapy.BIGL: Biochemically Intuitive Generalized Loewe null model for prediction of the expected combined effect compatible with partial agonism and antagonism.Identifying key regulating miRNAs in hepatocellular carcinomas by an omics' method.Neuroprotective Potential of Gentongping in Rat Model of Cervical Spondylotic Radiculopathy Targeting PPAR-γ Pathway.Neuroprotective Drug for Nerve Trauma Revealed Using Artificial Intelligence.The Effect of Triptolide in Rheumatoid Arthritis: From Basic Research towards Clinical Translation.Relationship between and polymorphisms and susceptibility to non-small-cell lung cancer: a case-control study in Eastern Chinese Han population Prognostic value of and in resected non-small cell lung cancer: a systematic review and meta-analysis

P2860

Q38623790-EBB4D53A-9438-42A2-B02E-1230C8BD1D01 Q41547474-D7937929-D93E-4693-BA1D-DCD41C5940CC Q47101320-CC05C03F-4D4E-4DC1-A6B7-4C7E7CCE9D1A Q47127018-447D5E84-54B0-4E4A-A458-910CA49C44E3 Q47259552-8EB06DA3-8A6F-47FC-A7E0-94D497AD7168 Q47554585-516F79CB-A17F-45F9-8F69-BD897A922E20 Q48159281-CC2826F6-5C26-478A-9DE5-CACC3852F7DB Q57167119-00D6C63F-0E6F-47AF-A80F-A42D28D83C7F Q58754535-C7A458C8-7A3D-433F-95D4-8ADD14F0C4B9

P2860

Combination therapeutics in complex diseases

http://www.wikidata.org/entity/Q28076891

description

2016 nî lūn-bûn

@nan

2016 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Combination therapeutics in complex diseases

@ast

Combination therapeutics in complex diseases

@en

Combination therapeutics in complex diseases

@nl

type

label

Combination therapeutics in complex diseases

@ast

Combination therapeutics in complex diseases

@en

Combination therapeutics in complex diseases

@nl

prefLabel

Combination therapeutics in complex diseases

@ast

Combination therapeutics in complex diseases

@en

Combination therapeutics in complex diseases

@nl

P1433

Q28076891-3A95436A-3239-4449-B534-035DFE2346D2

P1476

Q28076891-5BE3CF21-4C04-4F8F-890A-77419057BE5A

P2093

Q28076891-15130D9D-A896-4E18-9B77-823ED2FD1C44

Q28076891-23E4C2C1-EEFC-4CA7-82A6-76866FF7FAF3

Q28076891-26756B88-E5DE-4571-8112-AACEA3ED75E0

Q28076891-27285C71-C526-4BF9-BEF2-B2A045A5F606

Q28076891-85A26F7B-6513-4517-B5CF-FC24C5FC63B0

Q28076891-A5519639-B326-4046-93A2-74E416B00F5D

Q28076891-D6D87BD5-4523-4E69-8F3D-CBA08EBB1AED

P275

Q28076891-0E30E458-0698-4D40-A188-FE7B13A6D5EE

P2860

Q28076891-069DBFCD-9ECE-4D38-B339-6BC95DE8B035

Q28076891-08895CE8-2255-4680-8801-CF65D86B9511

Q28076891-08C1B619-B306-4FB4-B47F-3911CE2A95EE

Q28076891-0C27BBAE-1458-4B38-B8FE-82F59B833774

Q28076891-0C65C88F-FDB7-4160-AD83-569D04A32FCD

Q28076891-0C7AA3A9-FDAA-48CE-BBDD-CA54AC8C7DCD

Q28076891-0CC3186F-F962-4DF1-B41E-35BCF6C31320

Q28076891-0D2CD8D5-D27B-41EA-A295-B90FA799F436

Q28076891-110A6D5B-93F1-4657-B367-B1102A30B5D5

Q28076891-113D64CE-B5F1-473A-B853-5277AC0D0435

P304

Q28076891-BF88A1C9-1C2F-4EAC-ADAA-A5305F9DB84B

P31

Q28076891-2536BD28-65D7-4259-9AE3-18B69D2EF776

Q28076891-3CEE7F01-C112-4BF6-B85D-C9249C708D63

P3181

Q28076891-07D548DA-DAF1-482E-BE00-648277538AA7

P356

Q28076891-C2D0ACF6-181D-4EDB-B44B-9BCF973A7629

P407

Q28076891-904B1A62-B6F7-429A-B036-94DE8BF5F208

P433

Q28076891-B21C13F3-E7AC-4D58-9234-A79776547964

P478

Q28076891-34DBE373-C741-48D7-BDA0-C47D4A95FB5B

P50

Q28076891-7FF7A3D1-1854-48D1-A77F-20FB5A49BD9A

P577

Q28076891-2B61BF71-2FF3-43FC-9E2F-2E6A36879BF7

Q28076891-6595FA42-30E1-4138-88ED-A2167339F7CF

P698

Q28076891-6A1A00FC-BB34-4EC4-8982-CCD88E2FC3AD

P921

Q28076891-6943FB48-11CF-4789-A87A-76AEA7649878

P932

Q28076891-FA4E6524-C2D4-473F-9188-29EF130CCB0C

P3181

P356

P1433

Journal of Cellular and Molecular Medicine

P1476

Combination therapeutics in complex diseases

@en

P2093

Aiping Lu

http://www.w3.org/2001/XMLSchema#string

Bing He

http://www.w3.org/2001/XMLSchema#string

Cheng Lu

http://www.w3.org/2001/XMLSchema#string

Gao Chen

http://www.w3.org/2001/XMLSchema#string

Guang Zheng

http://www.w3.org/2001/XMLSchema#string

Maolin Wang

http://www.w3.org/2001/XMLSchema#string

Xiaojuan He

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution

P2860

Passenger deletions generate therapeutic vulnerabilities in cancer

Network-based approaches in drug discovery and early development

Nivolumab plus ipilimumab in advanced melanoma.

Improved overall survival in melanoma with combined dabrafenib and trametinib.

Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer

A multi-label approach to target prediction taking ligand promiscuity into account

Quantitative modeling of dose–response and drug combination based on pathway network

Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis

WNT signaling in bone homeostasis and disease: from human mutations to treatments

Genes affecting the cell cycle, growth, maintenance, and drug sensitivity are preferentially regulated by anti-HER2 antibody through phosphatidylinositol 3-kinase-AKT signaling

P304

2231-2240

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3639381

http://www.w3.org/2001/XMLSchema#string

P356

10.1111/JCMM.12930

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27605177

http://www.w3.org/2001/XMLSchema#string

P921

pharmaceutical preparation

P932

5134672

http://www.w3.org/2001/XMLSchema#string